Description:
Gilead Sciences, Inc. is a leading American biopharmaceutical company based in Foster City, California, dedicated to the research and development of innovative antiviral therapies for a range of infectious diseases, including HIV, hepatitis B, hepatitis C, and influenza. The company's notable products, such as Harvoni and Sovaldi, have transformed the treatment landscape for chronic hepatitis C and are at the forefront of its extensive drug portfolio. Gilead continues to leverage its pioneering research capabilities to address unmet medical needs and expand its therapeutic offerings, positioning itself as a crucial player in global healthcare.
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
333 LAKESIDE DRIVE, FOSTER CITY, CA, UNITED STATES, 94404
Fiscal year end:
December
Market capitalization:
$140 Billion
Dividend per share:
$3.12
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
+61%
How much will you get:
$1,609
Prices dates:
30-09-2015: $69.00 and 30-09-2025: $111.00